Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Neuberger Berman High Yield Strategies FundNHS -0.08%44 5-Year Yield-on-Cost % is 17.44 as of Jul. 14, 2026, which is 88% above its 10-year median of 9.29. GuruFocus rates NHS with a GF Score™ of 44/100 and a GF Value™ of $7.23 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 1,114 Asset Management companies, Neuberger Berman High Yield Strategies Fund ranks better than 91.2% on this metric.
NHS's 5-Year Yield-on-Cost % is ranked better than 91.2% of 1114
companies
in the Asset Management industry
Industry Median: 6.45
vs NHS: 17.44
Neuberger Berman High Yield Strategies Fund (AMEX:NHS) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Neuberger Berman High Yield Strategies Fund 5-Year Yield-on-Cost % Related Terms
NHS vs NRO, TPVG, OPP: 5-Year Yield-on-Cost % Comparison
For the Asset Management subindustry, Neuberger Berman High Yield Strategies Fund's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neuberger Berman High Yield Strategies Fund 5-Year Yield-on-Cost % vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Neuberger Berman High Yield Strategies Fund's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Neuberger Berman High Yield Strategies Fund's 5-Year Yield-on-Cost % falls into.
Neuberger Berman High Yield Strategies Fund 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Neuberger Berman High Yield Strategies Fund (NHS) has a 5-Year Yield-on-Cost % of 17.44 as of Jul. 14, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Neuberger Berman High Yield Strategies Fund and its competitors. This is 88% above median its historical median of 9.29. Over the past decade, Neuberger Berman High Yield Strategies Fund's 5-Year Yield-on-Cost % has ranged from 6.20 to 17.65. According to the industry distribution chart, Neuberger Berman High Yield Strategies Fund ranks #98 out of 1114 companies in the Asset Management industry, placing it in the top 8.8%.
Is Neuberger Berman High Yield Strategies Fund's 5-Year Yield-on-Cost % too high?
Neuberger Berman High Yield Strategies Fund's current 5-Year Yield-on-Cost % of 17.44 is 88% above median its 10-year median of 9.29. Over the past 10 years, this metric has ranged from a low of 6.20 to a high of 17.65. The Asset Management industry median 5-Year Yield-on-Cost % is 6.45. Neuberger Berman High Yield Strategies Fund's value of 17.44 is 170.4% above this industry median. Based on the distribution chart, Neuberger Berman High Yield Strategies Fund ranks #98 out of 1114 companies in the Asset Management industry, which is in the top quartile — a strong position relative to peers. Overall, Neuberger Berman High Yield Strategies Fund has a GF Score™ of 44/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Neuberger Berman High Yield Strategies Fund's 5-Year Yield-on-Cost % compare to NRO and TPVG?
According to the Asset Management industry distribution chart, Neuberger Berman High Yield Strategies Fund ranks #98 out of 1114 companies for 5-Year Yield-on-Cost %. This places Neuberger Berman High Yield Strategies Fund in the top 9% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 6.45. Neuberger Berman High Yield Strategies Fund's value of 17.44 is 170.4% above this benchmark. Historically, Neuberger Berman High Yield Strategies Fund's own 5-Year Yield-on-Cost % has ranged from 6.20 to 17.65 over the past decade. While the company's 10-year median is 9.29 vs. the industry median of 6.45, Neuberger Berman High Yield Strategies Fund has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for an Asset Management company?
The median 5-Year Yield-on-Cost % among Asset Management companies is 6.45, based on 1,114 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Neuberger Berman High Yield Strategies Fund's current 5-Year Yield-on-Cost % of 17.44 is 170.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Neuberger Berman High Yield Strategies Fund and its competitors. For the Asset Management industry, the median 5-Year Yield-on-Cost % is 6.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neuberger Berman High Yield Strategies Fund's current 5-Year Yield-on-Cost % is 17.44, which is 88% above median its own 10-year median of 9.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuberger Berman High Yield Strategies Fund stock overvalued right now?
Based on GuruFocus' analysis, Neuberger Berman High Yield Strategies Fund (NHS) is currently considered Modestly Undervalued. The stock's GF Value™ is $7.23, compared to a current price of $6.20 — trading 14.3% below its estimated fair value. The current 5-Year Yield-on-Cost % is 17.44, which is 88% above median its 10-year median of 9.29 and 170.4% above the Asset Management industry median of 6.45. Neuberger Berman High Yield Strategies Fund's overall GF Score™ is 44/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Neuberger Berman High Yield Strategies Fund (NHS), the current 5-Year Yield-on-Cost % is 17.44 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Neuberger Berman High Yield Strategies Fund (NHS) Overvalued in 2026?
Based on GuruFocus' analysis, Neuberger Berman High Yield Strategies Fund stock appears to be undervalued.
The current stock price of $6.20 is trading 14.3% below its estimated GF Value™ of $7.23.
GuruFocus considers Neuberger Berman High Yield Strategies Fund to be Modestly Undervalued.
Key valuation signals for NHS:
5-Year Yield-on-Cost %: 17.44 (88% above median its 10-year median of 9.29)
GF Value™: $7.23 vs. price of $6.20 (14.3% below fair value)
Industry Position: 170.4% above the Asset Management median (#98 of 1114)
No single metric tells the full story. See the NHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Neuberger Berman High Yield Strategies Fund Business Description
Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.
44GF Score
Get the complete analysis for NHS
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NHS has been successfully added to your 
